» Articles » PMID: 36421473

New Insights into the Gut Microbiota in Neurodegenerative Diseases from the Perspective of Redox Homeostasis

Overview
Date 2022 Nov 24
PMID 36421473
Authors
Affiliations
Soon will be listed here.
Abstract

An imbalance between oxidants and antioxidants in the body can lead to oxidative stress, which is one of the major causes of neurodegenerative diseases. The gut microbiota contains trillions of beneficial bacteria that play an important role in maintaining redox homeostasis. In the last decade, the microbiota-gut-brain axis has emerged as a new field that has revolutionized the study of the pathology, diagnosis, and treatment of neurodegenerative diseases. Indeed, a growing number of studies have found that communication between the brain and the gut microbiota can be accomplished through the endocrine, immune, and nervous systems. Importantly, dysregulation of the gut microbiota has been strongly associated with the development of oxidative stress-mediated neurodegenerative diseases. Therefore, a deeper understanding of the relationship between the gut microbiota and redox homeostasis will help explain the pathogenesis of neurodegenerative diseases from a new perspective and provide a theoretical basis for proposing new therapeutic strategies for neurodegenerative diseases. In this review, we will describe the role of oxidative stress and the gut microbiota in neurodegenerative diseases and the underlying mechanisms by which the gut microbiota affects redox homeostasis in the brain, leading to neurodegenerative diseases. In addition, we will discuss the potential applications of maintaining redox homeostasis by modulating the gut microbiota to treat neurodegenerative diseases, which could open the door for new therapeutic approaches to combat neurodegenerative diseases.

Citing Articles

Lactobacilli Cell-Free Supernatants Modulate Inflammation and Oxidative Stress in Human Microglia via NRF2-SOD1 Signaling.

Di Chiano M, Rocchetti M, Spano G, Russo P, Allegretta C, Milior G Cell Mol Neurobiol. 2024; 44(1):60.

PMID: 39287687 PMC: 11408562. DOI: 10.1007/s10571-024-01494-1.


Gut Microbiome Interactions with Oxidative Stress: Mechanisms and Consequences for Health.

Semenova N, Garashchenko N, Kolesnikov S, Darenskaya M, Kolesnikova L Pathophysiology. 2024; 31(3):309-330.

PMID: 39051221 PMC: 11270257. DOI: 10.3390/pathophysiology31030023.


Co-administration of probiotics and vitamin D reduced disease severity and complications in patients with Parkinson's disease: a randomized controlled clinical trial.

Zali A, Hajyani S, Salari M, Tajabadi-Ebrahimi M, Mortazavian A, Pakpour B Psychopharmacology (Berl). 2024; 241(9):1905-1914.

PMID: 38805039 DOI: 10.1007/s00213-024-06606-9.


The role of neuroinflammation in neurodegenerative diseases: current understanding and future therapeutic targets.

Adamu A, Li S, Gao F, Xue G Front Aging Neurosci. 2024; 16:1347987.

PMID: 38681666 PMC: 11045904. DOI: 10.3389/fnagi.2024.1347987.


The role of gut microbiota in intestinal disease: from an oxidative stress perspective.

Sun Y, Wang X, Li L, Zhong C, Zhang Y, Yang X Front Microbiol. 2024; 15:1328324.

PMID: 38419631 PMC: 10899708. DOI: 10.3389/fmicb.2024.1328324.


References
1.
Singhal A, Morris V, Labhasetwar V, Ghorpade A . Nanoparticle-mediated catalase delivery protects human neurons from oxidative stress. Cell Death Dis. 2013; 4:e903. PMC: 3847304. DOI: 10.1038/cddis.2013.362. View

2.
Saresella M, Marventano I, Barone M, La Rosa F, Piancone F, Mendozzi L . Alterations in Circulating Fatty Acid Are Associated With Gut Microbiota Dysbiosis and Inflammation in Multiple Sclerosis. Front Immunol. 2020; 11:1390. PMC: 7358580. DOI: 10.3389/fimmu.2020.01390. View

3.
Liguori I, Russo G, Curcio F, Bulli G, Aran L, Della-Morte D . Oxidative stress, aging, and diseases. Clin Interv Aging. 2018; 13:757-772. PMC: 5927356. DOI: 10.2147/CIA.S158513. View

4.
Vogt N, Kerby R, Dill-McFarland K, Harding S, Merluzzi A, Johnson S . Gut microbiome alterations in Alzheimer's disease. Sci Rep. 2017; 7(1):13537. PMC: 5648830. DOI: 10.1038/s41598-017-13601-y. View

5.
Aalinkeel R, Kutscher H, Singh A, Cwiklinski K, Khechen N, Schwartz S . Neuroprotective effects of a biodegradable poly(lactic-co-glycolic acid)-ginsenoside Rg3 nanoformulation: a potential nanotherapy for Alzheimer's disease?. J Drug Target. 2017; 26(2):182-193. DOI: 10.1080/1061186X.2017.1354002. View